课题基金 / 基金详情

A unique model of inflammatory bowel disease.

A unique model of inflammatory bowel disease.
炎症性肠病的独特模型。
批准号:
nhmrc : 114401
负责人:
Prof Anthony D'Apice
金额:
$23.51万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2000
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2000-01-01 至 2002-12-31

项目摘要

项目成果

Prof Anthony D'Apice的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Inflammatory Bowel Disease (IBD) has two clinical forms known as Ulcerative Colitis (UC) and Crohn's Disease (CD). These are severe diseases which predominantly affect young people. They are occasionally fatal and often severely debilitating. Treatment of UC frequently requires removal of the large bowel and life long wearing of an ileostomy bag. While this is curative, its psychological and life style effects are very disturbing particularly in the young. The cause of IBD is unknown, although it is clear that there are both genetic and environmental factors. We have developed a model of IBD in mice which appears to be very like human UC. We have generated genetically modified mice in which it appears that the mucous secreted by their bowel wall is different from normal. We propose to investigate how this change leads to UC. It appears likely that the mucous is defective and can not prevent some of the normal bacteria or other material present in the stools from entering the bowel wall and causing chronic inflammation. If we can show that this is the case, it adds strong support to the the idea that a similar genetic trait may occur in some humans and that this may be one of the genetic components which renders them susceptible to IBD. Put another way, it would be a pointer to the type of genetic defect which may underlie susceptibility in humans and so help to focus the search for the genetic component. Understanding genetic factors underlying disease susceptibility is vitally important to inform genetic counselling. In addition, understanding the various factors which lead to IBD is critical to developing rational treatments which target cause rather than the symptoms of the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of recombinant rsolCD39-PSGL as a novel therapeutic with anti-thrombotic and anti-inflammatory effects
  • 批准号:
    nhmrc : 520697
  • 项目类别:
    NHMRC Development Grants
  • 资助金额:
    $12.43万
  • 财政年份:
    2008
  • 负责人:
    Prof Anthony D'Apice
  • 依托单位:
CD39 protects against renal ischaemic-reperfusion injury
  • 批准号:
    nhmrc : 447706
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $29.44万
  • 财政年份:
    2007
  • 负责人:
    Prof Anthony D'Apice
  • 依托单位:
A novel CD39-like ecto-NTPDase of Legionella pneumophila
  • 批准号:
    nhmrc : 436607
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $24.14万
  • 财政年份:
    2007
  • 负责人:
    Prof Anthony D'Apice
  • 依托单位:
Antithrombotic effect of NTPDase1/CD39
  • 批准号:
    nhmrc : 344801
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $24.62万
  • 财政年份:
    2005
  • 负责人:
    Prof Anthony D'Apice
  • 依托单位:
国内基金
海外基金
基于术中实时影像的SAM(Segment anything model)开发AI指导房间隔穿刺位置决策的增强现实模型
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    居维竹
  • 依托单位:
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
  • 批准号:
    82370684
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    傅强
  • 依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
  • 批准号:
    82371912
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    吴广宇
  • 依托单位:
高维隐含因子与定价误差的协同估计
  • 批准号:
    72101226
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    丁一
  • 依托单位: